Literature DB >> 21933712

Dicer-substrate siRNA inhibits tumor necrosis factor alpha secretion in Kupffer cells in vitro: in vivo targeting of Kupffer cells by siRNA-liposomes.

Sivakamasundari Pichu1, Swapna Krishnamoorthy, Bi Zhang, Yawu Jing, Andrei Shishkov, Biddanda C Ponnappa.   

Abstract

Tumor necrosis factor alpha (TNF-α) plays a major role in the pathogenesis of many inflammatory diseases. Neutralizing TNF-α by antibodies or antisense oligodeoxynucleotides, alleviate disease symptoms. In this study, we introduce the new generation of gene-silencing molecules, namely the small interfering RNAs (siRNAs) to reduce TNF-α. Although siRNAs of 19-21bp are commonly used, it is reported that longer siRNAs have much higher efficacies. Here, we report the identification of a 27-mer Dicer-substrate siRNA (DsiRNA) against TNF-α mRNA. Primary cells of rat Kupffer cells were transfected with five 27-mer siRNA constructs (si27-1, si27-2 si27-3, si27-4 and si27-5) for 24h, following which, TNF-α secretion was induced by exposure to LPS (0.1μg/ml) for 2h. TNF-α released to the medium was measured by ELISA. Of the five si27 constructs, si27-3 had the highest inhibitory effect on TNF-α secretion. At 10nM, si27-3 inhibited TNF-α secretion by 80% compared to a 60% inhibition by a 21-mer (SSL3). Following encapsulation in anionic liposomes, si27-3 at 100μg/kg body weight, on two successive days by intravenous administration, inhibited the secretion of TNF-α by 50%. These data demonstrate the identification of a highly efficacious siRNA formulation, which can be used in the treatment of TNF-α mediated diseases.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933712      PMCID: PMC3264835          DOI: 10.1016/j.phrs.2011.09.001

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  35 in total

Review 1.  Biologically active products of stimulated liver macrophages (Kupffer cells).

Authors:  K Decker
Journal:  Eur J Biochem       Date:  1990-09-11

2.  pH-sensitive liposomes for delivery of macromolecules into cytoplasm of cultured cells.

Authors:  R M Straubinger
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

3.  Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.

Authors:  S H Murch; C P Braegger; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

4.  Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods.

Authors:  A A Nanji; S Zhao; S M Sadrzadeh; D J Waxman
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

5.  Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen.

Authors:  D L Laskin; C R Gardner; V F Price; D J Jollow
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

6.  Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease.

Authors:  S Kamimura; H Tsukamoto
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

7.  Inactivation of Kupffer cells prevents early alcohol-induced liver injury.

Authors:  Y Adachi; B U Bradford; W Gao; H K Bojes; R G Thurman
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

8.  Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

Authors:  M J Elliott; R N Maini; M Feldmann; J R Kalden; C Antoni; J S Smolen; B Leeb; F C Breedveld; J D Macfarlane; H Bijl
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

9.  Increased tumor necrosis factor production by monocytes in alcoholic hepatitis.

Authors:  C J McClain; D A Cohen
Journal:  Hepatology       Date:  1989-03       Impact factor: 17.425

10.  Role of the spleen in endotoxin-induced hepatic injury in chronic alcohol-fed rats.

Authors:  S Tanaka; R Kumashiro; K Tanikawa
Journal:  Liver       Date:  1992-10
View more
  3 in total

1.  Evaluation of canonical siRNA and Dicer substrate RNA for inhibition of hepatitis C virus genome replication--a comparative study.

Authors:  Bruno Carneiro; Ana Cláudia Silva Braga; Mariana Nogueira Batista; Mark Harris; Paula Rahal
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

2.  Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development.

Authors:  Valérie Bégin-Lavallée; Élora Midavaine; Marc-André Dansereau; Pascal Tétreault; Jean-Michel Longpré; Ashley M Jacobi; Scott D Rose; Mark A Behlke; Nicolas Beaudet; Philippe Sarret
Journal:  Mol Pain       Date:  2016-06-15       Impact factor: 3.395

Review 3.  Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA.

Authors:  Maria Abdul Ghafoor Raja; Haliza Katas; Muhammad Wahab Amjad
Journal:  Asian J Pharm Sci       Date:  2019-02-13       Impact factor: 6.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.